H

Huaxia Eye Hospital Group Co Ltd
SZSE:301267

Watchlist Manager
Huaxia Eye Hospital Group Co Ltd
SZSE:301267
Watchlist
Price: 18.19 CNY -0.22%
Market Cap: ¥15.3B

P/B

2.5
Current
15%
Cheaper
vs 3-y average of 3

Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.

P/B
2.5
=
Market Cap
¥14.5B
/
Total Equity
¥6B

Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.

P/B
2.5
=
Market Cap
¥14.5B
/
Total Equity
¥6B

Valuation Scenarios

Huaxia Eye Hospital Group Co Ltd is trading below its 3-year average

If P/B returns to its 3-Year Average (3), the stock would be worth ¥21.35 (17% upside from current price).

Statistics
Positive Scenarios
2/4
Maximum Downside
-11%
Maximum Upside
+21%
Average Upside
6%
Scenario P/B Value Implied Price Upside/Downside
Current Multiple 2.5 ¥18.19
0%
3-Year Average 3 ¥21.35
+17%
5-Year Average 3.1 ¥22.06
+21%
Industry Average 2.3 ¥16.2
-11%
Country Average 2.4 ¥17.49
-4%

Forward P/B
Today’s price vs future total equity

Not enough data available to calculate forward P/B

Peer Comparison

All Multiples
P/B
P/E
All Countries
Close

Market Distribution

In line with most companies in China
Percentile
52st
Based on 7 605 companies
52st percentile
2.5
Low
0 — 1.5
Typical Range
1.5 — 3.9
High
3.9 —
Distribution Statistics
China
Min 0
30th Percentile 1.5
Median 2.4
70th Percentile 3.9
Max 1 172 445.9

Huaxia Eye Hospital Group Co Ltd
Glance View

Market Cap
15.3B CNY
Industry
Health Care

Huaxia Eye Hospital Group Co Ltd has positioned itself as a key player in China’s healthcare landscape, specializing in comprehensive ophthalmic services. Emerging from the early stirrings of China's reforms in the healthcare sector, Huaxia capitalized on a burgeoning demand for specialized medical care. With roots tracing back to when accessible eye care was a luxury in China, Huaxia recognized the immense potential in providing quality eye treatments. As the country urbanized rapidly, vision ailments became increasingly prevalent, creating a vast market for ocular health services. Huaxia seized this opportunity by establishing a network of state-of-the-art facilities across major cities, providing services ranging from basic eye examinations to complex surgeries. The company's revenue model is built on a multifaceted approach, combining patient volume with specialized treatments. Catering to a diverse demographic, Huaxia offers tiered service options that suit various financial capacities, ensuring a steady stream of income. Beyond individual consultations, the company has fostered partnerships with corporations and insurance providers, further securing a stable client base. Moreover, Huaxia invests significantly in pioneering medical technology and staff training, enhancing its reputation and thereby drawing more patients seeking top-notch care. Through strategic expansion and consistently leveraging advancements in ophthalmology, Huaxia Eye Hospital Group Co Ltd has solidified its place not just as a healthcare provider, but as a critical architect shaping the future of eye care in China.

Intrinsic Value
18.94 CNY
Undervaluation 4%
Intrinsic Value
Price ¥18.19
H
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett